Skin cancer — all decisions

The Board remands the claim for further development to determine if the immunotherapy treatment the Veteran is receiving qualifies as antineoplastic therapy.

The Board granted service connection for prostate cancer and skin lesion (claimed as melanoma) based on the evidence of record.

The Board denied service connection for actinic keratosis, chronic bronchitis, and tinnitus, as well as an increased evaluation for the acquired psychiatric disability.

The Board granted service connection for residuals of melanoma, squamous cell carcinoma, and depressive disorder, secondary to service-connected tinnitus.

The appeal of entitlement to service connection for obstructive sleep apnea, malignant growths of the skin (claimed as skin cancer (melanoma)), and residual scars associated with skin are dismissed due to a procedural defect in filing the claims.

The Board dismissed the appeal for entitlement to TDIU prior to December 22, 2021, and denied service connection for chronic fatigue, a neck condition, left upper extremity radiculopathy, and right upper extremity radiculopathy. The claims for skin cancer, ankylosing spondylitis/back condition, and a right foot/lower extremity neurological condition were remanded.

The appeal of proposed actions to sever service connection for multiple scars, status post excision of skin cancer, and to reduce the assigned disability rating from 100 percent to 30 precent for multiple basal cell carcinomas was dismissed. The appeal of issues for initial higher ratings for hypertension, PTSD, gastroesophageal reflux disorder with diverticulitis, and anemia, and issues for service connection for Parkinson's like symptoms, peripheral neuropathy in the lower and upper extremities, and low back disability were also dismissed.

The Board denied an earlier effective date for the grant of service connection for lumbosacral strain with degenerative disc disease and spinal stenosis, as well as remanded claims for service connection for a right foot condition, COPD, and skin cancer.

The Board denied service connection for various conditions, including skin cancer, GERD, arthritis, lung disability, sleep apnea, vertigo, tremors, and multiple types of radiculopathy. The Veteran did not meet the criteria for specially adapted housing or special home adaptation.

The Board remands the issue of service connection for melanoma as it requires a VA examination to determine if there is a nexus between the Veteran's in-service sun exposure and his current diagnosis.

The Board dismissed the claims for service connection for shortness of breath, endocarditis, lipoma, and skin cancer as the Veteran withdrew his appeal. The claim for peripheral arterial disease was denied due to a lack of evidence supporting a current diagnosis. Service connection for a back condition was also denied due to insufficient evidence linking it to service.

The Board denied service connection for benign prostatic hyperplasia and remanded the claims for left hand malignant melanoma, malignant melanoma of the face, heart disability, aortic aneurysm, and peripheral vascular disease of both lower extremities.

The Veteran's application for Legacy Service-Disabled Veterans Insurance (Legacy S-DVI) is granted, as his history of malignant melanoma no longer precludes a finding of good health.

The Board denied increased ratings for right foot plantar fasciitis, sinusitis, and scars, and remanded the claim for service connection for a left hip condition.

The Board granted an effective date of May 19, 2022, for the award of service connection for the cause of the Veteran's death.

The Board denied service connection for skin cancer, diabetes type II, and teeth loss as they were not etiologically related to the Veteran's active-duty service. The Board also denied service connection for the cause of the Veteran's death.

The Board denied the Veteran's claim for service connection for basal cell skin cancer, finding no evidence of a direct causal relationship between the condition and his military service, including exposure to herbicides.

The Board remands the claims for new VA medical opinions to address the etiology of the Veteran's respiratory cancer and skin cancer, as well as further development regarding potential exposures in service.

The Board granted an effective date of February 24, 2023, for the grant of service connection for melanoma residuals and denied a compensable rating for those residuals.

The Board dismissed the claim for service connection for high blood pressure as it was not appealed within one year of the final denial in 2016. The claims for skin cancer and essential tremors were remanded to correct pre-decisional duty to assist errors.